Stem-cell-like T cells have a specific entry gate to the tumor

Cancer Cell. 2022 Mar 14;40(3):243-245. doi: 10.1016/j.ccell.2022.02.004. Epub 2022 Feb 16.

Abstract

Tumor-infiltrated T cells with stem-cell-like properties are important for determining the immunotherapy response. In this issue of Cancer Cell, Asrir and colleagues show that their entry requires specialized tumor-associated endothelial cells that resemble immature and inflamed lymph node vessels and that immunotherapy enhances the recruitment capacity of these endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • CTLA-4 Antigen
  • Endothelial Cells
  • Humans
  • Immunotherapy
  • Lymph Nodes / pathology
  • Lymphocytes
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Programmed Cell Death 1 Receptor
  • T-Lymphocytes* / pathology
  • Venules / pathology

Substances

  • CTLA-4 Antigen
  • Programmed Cell Death 1 Receptor